Vol 71, No 5 (2021)
Invited editorial
Published online: 2021-10-13

open access

Page views 6144
Article views/downloads 474
Get Citation

Connect on Social Media

Connect on Social Media

RECIST criteria and clinical practice

Piotr J. Wysocki1
Nowotwory. Journal of Oncology 2021;71(5):319-320.

Abstract

Not available

Article available in PDF format

View PDF Download PDF file

References

  1. Miller AB, Hoogstraten B, Staquet M, et al. Reporting results of cancer treatment. Cancer. 1981; 47(1): 207–214, doi: 10.1002/1097-0142(19810101)47:1<207::aid-cncr2820470134>3.0.co;2-6.
  2. Therasse P, Arbuck S, Eisenhauer E, et al. New Guidelines to Evaluate the Response to Treatment in Solid Tumors. J Natl Cancer Inst. 2000; 92(3): 205–216.
  3. Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1). Eur J Cancer. 2009; 45(2): 228–247.
  4. Seymour L, Bogaerts J, Perrone A, et al. iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics. The Lancet Oncology. 2017; 18(3): e143–e152.
  5. Płużański A. Evaluation of response to treatment — criteria RECIST 1.1. Nowotwory. Journal of Oncology. 2014; 64(4): 331–335.



Nowotwory. Journal of Oncology